West Pharmaceutical Services WST Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's pre-tax income?
- West Pharmaceutical Services (WST) reported pre-tax income of $180.1M in Q2 2026.
- How has West Pharmaceutical Services's pre-tax income changed year-over-year?
- West Pharmaceutical Services's pre-tax income increased by 14.7% year-over-year, from $157M to $180.1M.
- What is the long-term trend for West Pharmaceutical Services's pre-tax income?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's pre-tax income has grown at a -5.4% compound annual growth rate (CAGR), from $748.9M to $600.9M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.